| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06285825 | A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged… | Cytopenia | Recruiting |
| NCT05787574 | A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary… | Primary Immune Regulatory Disorder | Recruiting |
| NCT07486869 | Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study | Dermatomyositis | Not Yet Recruiting |
| NCT07538336 | Targeting Interferon Gamma With Emapalumab to Lung Transplant Recipients With Interferon… | Lung Transplant | Not Yet Recruiting |
| NCT07567014 | Emapalumab Prophylaxis of Bispecific T-Cell Engagers (BiTEs) Associated CRS and ICANS | Multiple Myeloma | Not Yet Recruiting |
| Phase 1 | |||
| NCT06996119 | Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil… | Acute Myeloid Leukemia | Recruiting |
| Early Phase 1 | |||
| NCT07244419 | Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients | Hematopoietic Stem Cell Transplantation | Recruiting |